Latest DDD-exit: MTHFD2 inhibitor for AML treatment
SciLifeLab researcher Thomas Helleday (Karolinska Institutet) and his group have investigated the role folate metabolism enzyme (MTHFD2) plays in DNA replication and genomic stability of cancer cells. The researchers validates … Continue reading Latest DDD-exit: MTHFD2 inhibitor for AML treatment
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed